COVID-19 pandemic impact on the pharmaceutical sector in Bulgaria
In December, 2019 in Wuhan, Hubei Province, China, a new, unknown strain of coronavirus called SARS-CoV-2 was identified. The virus has spread rapidly to other countries around the world, among which the most affected were Italy, Spain and the United States. As a result, in March 2020 The WHO has de...
Saved in:
Main Authors: | Veselina Ivanova (Author), Deyan Pavlov (Author), Tolya Assenova (Author), Emily Terzieva (Author), Petya Milushewa (Author), Alime Djemadan (Author), Gergana Vladimirova (Author), Maria Dimitrova (Author), Maria Kamusheva (Author) |
---|---|
Format: | Book |
Published: |
Pensoft Publishers,
2021-09-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Rare disease patients' needs: an up-to-date analysis and future directions
by: Maria Kamusheva, et al.
Published: (2021) -
IMPLEMENTATION OF EU DIRECTIVES FOR CERTIFICATION OF THE STAFF IN THE SPA BUSINESS IN BULGARIA
by: Petya Kutincheva, et al.
Published: (2013) -
Impact of Polypharmacy, Drug-Related Problems, and Potentially Inappropriate Medications in Geriatric Patients and Its Implications for Bulgaria-Narrative Review and Meta-Analysis
by: Tzvetan Krustev, et al.
Published: (2022) -
Pharmacotherapeutic Patterns and Patients' Access to Pharmacotherapy for Some Rare Diseases in Bulgaria - A Pilot Comparative Study
by: Maria Kamusheva, et al.
Published: (2021) -
Evaluating potentially inappropriate medications in elderly patients in a pharmacy setting in Bulgaria: A pilot study utilizing the EU (7)-PIM List
by: Petya Milushewa, et al.
Published: (2023)